Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 13Breast 10Genitourinary 7Gastrointestinal 6Thoracic 5Sarcoma 3Head & Neck 3Gynecologic 3Plasma cell 2Myeloid 1Lymphoid 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 2Multiple Myeloma 2Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Fanconi Anemia 1

Interventions

Bortezomib 20Blood Specimen Collection 9Surveys and Questionnaires 8Lenalidomide 8Dexamethasone 8pomalidomide 6daratumumab 6Flow Cytometry 6Immunoenzyme Techniques 5Biopsy 5plerixafor 4idecabtagene vicleucel 4carfilzomib 4Standard of Care 4Polymerase Chain Reaction 4Amplified Fragment Length Polymorphism Analysis 4Specimen Handling 3Psychiatric Rehabilitation 3Patient Reported Outcome Measures 3Microarray Analysis 3Melphalan 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Drug Therapy 3Data Collection 3Cytogenetic Analysis 3Chromatin Immunoprecipitation Sequencing 3talquetamab 2selinexor 2belantamab mafodotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Reverse Transcriptase Polymerase Chain Reaction × Plasma cell × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT00899080 2017-05-17

Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide

Eastern Cooperative Oncology Group

Completed
33 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡